Investing in biotechs can be an exercise in frustration, as Lexicon Pharmaceuticals (NASDAQ:LXRX) so amply demonstrates. While I believe the company has continued to build a solid case that its dual SGLT-1/2 inhibitor sotagliflozin can and should be approved for use in Type 1 diabetes, the shares are down about 20% from the time of my last update. Although the data package on sotagliflozin is not....More>>>
Jamie Dimon spoke at the Institute of International Finance about cryptocurrencies.
He said blockchain technology is great and he finds digital currencies and cryptocurrencies useful. JPMorgan Chase & Co. (NYSE: JPM) moves $6 trillion every day digitally and doesn't use cash. He wouldn't have a problem if he had to move the money digitally with blockchain technology, because it....More>>>
Following past boom/bust cycles, the oil business appears to have bottomed in February 2016 at $27 a barrel. The bruising multi-year bust in crude oil prices was the biggest reason for the world stock market sell-off from late 2015 to early 2016 of roughly 15% overall. The cruel irony of ultra-low prices is its disruptive effect on regular exploration activity. A short-term oil market depression....More>>>
Longtime readers know Steve Sjuggerud is a true contrarian… Steve has made a career of recommending cheap, hated assets that most investors have no interest in owning… And he has a long track record of winners to show for it (including the best-performing recommendation in Stansberry Research history). But in last month's issue of his True Wealth Systems service,....More>>>
Stocks surged today as the results of the French presidential election have allowed investors to focus on earnings.
Photographer: Christophe Morin/Bloomberg
The S&P 500advanced 1.1% to 2374.15 today, while the Dow Jones Industrial Averagerose 216.13 points, or 1.1%, to 20,763.89. The Nasdaq Compositegained 1.2% to 5,983.82.
Morgan Stanley’s Michael Wilson and....More>>>
Doug Kass fills his blog on RealMoney every day with his up-to-the-minute reactions to what’s happening in the market and his legendary ahead-of-the-crowd ideas. This week he blogged on:
How the Fed hike may flatten the yield curve. How gold is doing.
Click here for information on RealMoney, where you can see all the blogs, including Doug Kass’–and reader comments–in....More>>>
The September FOMC meeting has become one of the most highly anticipated events of 2016 for market watchers.
That’s why today (Tuesday) we’re highlighting everything investors need to watch at the FOMC meeting on Sept. 20 and Sept. 21.
The Federal Reserve interest rate policy will naturally be the biggest topic to watch at the September FOMC meeting. And over the last....More>>>